{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T02:39:53.032947",
  "document": "Mucopolysaccharidosis-Type-I.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/test/Mucopolysaccharidosis-Type-I.pdf",
  "total_candidates": 17,
  "total_validated": 1,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "heuristics_counters": {
    "recovered_by_stats_whitelist": 0,
    "recovered_by_country_code": 0,
    "recovered_by_hyphen": 0,
    "recovered_by_direct_search": 0,
    "recovered_by_llm_sf_only": 0,
    "blacklisted_fp_count": 0,
    "common_word_rejected": 1,
    "context_rejected": 0,
    "form_filter_rejected": 0,
    "trial_id_excluded": 0
  },
  "abbreviations": [
    {
      "short_form": "MPS",
      "long_form": "mucopolysaccharidosis",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "s and females in equal numbers, with an incidence of about 1 in 100,000 live births for the severe type, and an incidence of about 1in 500,000 live births for the attenuated type. Incidence is the number of people who develop a disorder over a given period of time (e.g. one year). The incidence for MPS disorders collectively is about 1 in 25,000. However, rare disorders, especially milder forms of MPS, often go misdiagnosed or undiagnosed, making it difficult to determine the true frequency in the general population.",
      "lexicon_source": "meta-inventory",
      "lexicon_ids": null
    }
  ],
  "diseases": [
    {
      "name": "mucopolysaccharidosis",
      "matched_text": "Mucopolysaccharidosis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": "Orphanet:79213"
    }
  ],
  "drugs": [
    {
      "name": "MPS",
      "matched_text": "MPS",
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "phase": null
    }
  ],
  "pharma": []
}